Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
BBG Advanced Therapies is an Italian biotechnology company specializing in the development and manufacturing of Advanced Therapy Medicinal Products (ATMPs). The company operates as a Contract Development and Manufacturing Organization (CDMO), providing end-to-end services for cell and gene therapies, including process development, analytical validation, and GMP manufacturing. BBG Advanced Therapies focuses on bridging the gap between academic research and clinical application by offering specialized expertise in regulatory compliance and quality control for complex biological products. Their facilities are designed to support the production of innovative treatments for rare diseases and oncology, catering to both clinical trials and potential commercial supply.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on BBG Advanced Therapies.